CanBreed

growth-positive

Israeli genetics and seed company CanBreed is rebranding as BetterSeeds. The company has been successful in enhancing seeds using CRISPR technology, primarily focused on cannabis plants. BetterSeeds will now apply this technology to multiple crops, including cocoa, soy, peanuts, cucumbers, tomatoes, and black-eyed peas. The rebranding aims to expand the companys reach and improve crop varieties by embedding game-changing traits through gene editing. BetterSeeds aims to address the growing demand for food due to population growth, limited farming lands, and technological limitations. The company is led by experienced professionals in the seed industry and is positioning itself as a global leader in agricultural research and development.

growth-positive

Israel-based CanBreed has developed the first known stable and uniform cannabis hybrid seeds, solving the problem of genetic instability among growers. The company has completed the first uniform homozygous cannabis parental lines, ensuring the reproducibility and standardization of cannabis for the industry. CanBreed plans to start marketing the seeds in the first half of 2021. The news is growth-positive for the company.

growth-positive

Israeli genetic seeds company CanBreed, a portfolio company of the Smart Agro R&D Partnership, has purchased a farm in California to produce stable hemp seeds for the US market. CanBreed develops genetically improved and stable seeds using CRISPR gene editing technology. The company aims to provide solutions for various agricultural needs and target markets, including medical and industrial cannabis. CanBreed plans to bring its beta product, fully stable seeds, to market by the end of 2020. The construction of facilities and greenhouses on the newly acquired farm is scheduled to begin in early 2021, with sales of stable hemp seeds expected to start by the end of 2021. The Smart Agro partnership has invested $2 million in CanBreed.

growth-positive

Smart Agro, an agri-tech R&D partnership, plans to raise NIS 25 million on the Tel Aviv Stock Exchange (TASE) and invest $2 million in CanBreed, a company developing enhanced genetics for seeds using CRISPR gene editing technology. The IPO will be led by Leumi Partners Underwriters. Smart Agro is the first agri-tech R&D startup on the TASE, following an amendment to TASE regulations allowing public offerings of limited partnerships in R&D. CanBreed aims to apply CRISPR technology to agricultural crops, including seeds for the medical cannabis industry. The companys target markets are estimated to be worth billions of dollars. CanBreed plans to launch its beta product in the medical cannabis market by the end of the year.

growth-positive

Israel-based CanBreed has obtained a licensing agreement for foundational CRISPR-Cas9 patents, allowing them to use gene-editing technology in cannabis products. This will accelerate their efforts to supply farmers with improved cannabis varieties. However, they still face regulatory hurdles in Europe due to the EU GMO ban on CRISPR technology. CanBreed is working with partners such as Corteva Agriscience and the Broad Institute of MIT and Harvard. The company has raised an undisclosed amount in seed funding and consists of 13 employees, including nine scientists.

growth-positive

Israeli company CanBreed is developing cannabis-based tech to improve agriculture. Their main product, CRISPR-Cas9, aims to create disease-resistant plants. CanBreed provides genetically superior seeds to growers, ensuring standardized, high-quality cannabis for patients and consumers. The companys technology and genetics maintain consistency, uniformity, and profitability for growers. CanBreeds YieldMax platform contains all the agronomic traits needed for low-cost, high-quality production. Their F1 Hybrid seeds are uniform and stable, ensuring standardization and high quality of cannabis raw material. The company expects to begin exporting their products gradually in the third quarter of 2020. CanBreed was founded in 2017 by Ido Margalit and Tal Sherman.

growth-positive

Israeli startup CanBreed has reached a licensing agreement to use gene editing tools to provide cannabis growers with enhanced seeds for the production of medical grade cannabis. The company has developed stable cannabis seeds using CRISPR-Cas9 technology, which will allow farmers to grow cannabis from seeds instead of cloning. The use of gene editing tools will enable the creation of seeds with enhanced traits, such as disease resistance and adaptability to different growth environments. CanBreed aims to be a world leader in using CRISPR technology for cannabis and expects its stable seeds to be ready for sale by mid-2021.